Dunhill Financial’s Agilon Health AGL Stock Holding History

Dunhill Financial’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$40	–	1628
2026 Q1	$40	Buy	+5	New	+$81	﹤0.01%	1659
2025 Q4	–	Hold	0	–	–	–	2015

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dunhill Financial's AGL Position: Q2 2026 in Review

Dunhill Financial sold out of Agilon Health (AGL) in Q2 2026, closing a stake of 5 shares — an estimated $40 sold.

Dunhill Financial first reported a position in AGL in Q1 2026 and held it in 1 quarter. The position peaked at $40 in Q1 2026. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Dunhill Financial reported no remaining Agilon Health position as of Q2 2026 after selling out during the quarter.
Dunhill Financial sold 5 Agilon Health shares in Q2 2026, an estimated $40.
Dunhill Financial first reported a position in Agilon Health in Q1 2026 and held it in 1 quarter.
Dunhill Financial's Agilon Health position peaked at $40 in Q1 2026.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.